We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.22B
AUM Growth
+$186M
Cap. Flow
+$231M
Cap. Flow %
10.43%
Top 10 Hldgs %
42.94%
Holding
2,313
New
704
Increased
422
Reduced
406
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 6.33%
2 Healthcare 5.48%
3 Consumer Discretionary 4.35%
4 Industrials 3%
5 Real Estate 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLH icon
1726
Clean Harbors
CLH
$16.3B
-684
Closed -$49K
CLLS
1727
Cellectis
CLLS
$285M
-770
Closed -$12K
CMA
1728
DELISTED
Comerica
CMA
-765
Closed -$56K
CMCM
1729
Cheetah Mobile
CMCM
$96.5M
-515
Closed -$9K
CMCSA icon
1730
Comcast
CMCSA
$90B
-5,872
Closed -$260K
CMCSA icon
1731
PUT
Comcast
CMCSA
$90B
-75,000
Closed -$3.17M
CMG icon
1732
CALL
Chipotle Mexican Grill
CMG
$41.5B
-250,000
Closed -$3.66M
CMI icon
1733
Cummins
CMI
$88.7B
-2,413
Closed -$413K
CMRE icon
1734
Costamare
CMRE
$1.77B
-14,500
Closed -$74K
CNDT icon
1735
Conduent
CNDT
$264M
-7,860
Closed -$60.8K
CNX icon
1736
CNX Resources
CNX
$5.2B
-2,098
Closed -$15K
COF icon
1737
CALL
Capital One
COF
$134B
-1,800
Closed -$163K
COLL icon
1738
Collegium Pharmaceutical
COLL
$956M
-2,500
Closed -$33K
COR icon
1739
Cencora
COR
$61.2B
-936
Closed -$80K
CORT icon
1740
Corcept Therapeutics
CORT
$12B
-4,100
Closed -$46K
COTY icon
1741
Coty
COTY
$2.48B
-2,064
Closed -$28K
CPRX
1742
DELISTED
Catalyst Pharmaceutical
CPRX
-23,270
Closed -$89K
CPRI icon
1743
Capri Holdings
CPRI
$1.74B
-25,742
Closed -$893K
CPT icon
1744
Camden Property Trust
CPT
$11.3B
-19,955
Closed -$2.08M
CRESY
1745
Cresud
CRESY
$773M
-645
Closed -$6K
CRMT icon
1746
America's Car Mart
CRMT
$26.9M
-108
Closed -$9K
CRSP icon
1747
CRISPR Therapeutics
CRSP
$5.17B
-7,446
Closed -$351K
CSX icon
1748
CSX Corp
CSX
$93.1B
-1,662
Closed -$43K
CSX icon
1749
PUT
CSX Corp
CSX
$93.1B
-57,000
Closed -$1.47M
CTMX icon
1750
CytomX Therapeutics
CTMX
$754M
-611
Closed -$7K

Similar funds

Prelude Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Prelude Capital Management held 2,313 positions worth $2.22B, up 9.1% from $2.03B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Prelude Capital Management deployed $231M of net new capital in Q3 2019, opening 704 new positions and adding to 422 existing holdings. Its largest new stake was Callon Petroleum Company: 418,579 shares worth $18.2M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Stewart Information Services, an estimated $7.45M trimmed.

  • Prelude Capital Management's largest Q3 2019 buy was Callon Petroleum Company: 418,579 shares worth $18.2M.
  • Prelude Capital Management added most to Altaba Inc in Q3 2019, an estimated $29.3M increase.
  • Prelude Capital Management's biggest Q3 2019 reduction was Stewart Information Services, cutting an estimated $7.45M.
  • Prelude Capital Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $41.9M.
  • Prelude Capital Management's ten largest holdings make up 43% of its $2.22B portfolio in Q3 2019.
  • Prelude Capital Management opened 704 new positions and closed 646 in Q3 2019.
  • Prelude Capital Management's portfolio value rose 9.1% quarter-over-quarter to $2.22B.

Based on Prelude Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.